Pharmaphorum Media Limited - Accounts to registrar (filleted) - small 23.2.5

Pharmaphorum Media Limited - Accounts to registrar (filleted) - small 23.2.5


IRIS Accounts Production v23.2.0.158 07254094 Board of Directors 1.1.22 31.12.22 31.12.22 11.9.2023 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure072540942021-12-31072540942022-12-31072540942022-01-012022-12-31072540942020-12-31072540942021-01-012021-12-31072540942021-12-3107254094ns16:EnglandWales2022-01-012022-12-3107254094ns15:PoundSterling2022-01-012022-12-3107254094ns11:Director12022-01-012022-12-3107254094ns11:PrivateLimitedCompanyLtd2022-01-012022-12-3107254094ns11:SmallEntities2022-01-012022-12-3107254094ns11:Audited2022-01-012022-12-3107254094ns11:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3107254094ns11:SmallCompaniesRegimeForAccounts2022-01-012022-12-3107254094ns11:FullAccounts2022-01-012022-12-310725409412022-01-012022-12-3107254094ns11:Director22022-01-012022-12-3107254094ns11:Director32022-01-012022-12-3107254094ns11:CompanySecretary12022-01-012022-12-3107254094ns11:RegisteredOffice2022-01-012022-12-3107254094ns6:CurrentFinancialInstruments2022-12-3107254094ns6:CurrentFinancialInstruments2021-12-3107254094ns6:ShareCapital2022-12-3107254094ns6:ShareCapital2021-12-3107254094ns6:RetainedEarningsAccumulatedLosses2022-12-3107254094ns6:RetainedEarningsAccumulatedLosses2021-12-3107254094ns6:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3107254094ns6:LeaseholdImprovements2022-01-012022-12-3107254094ns6:FurnitureFittings2022-01-012022-12-3107254094ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-12-3107254094ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-01-012022-12-3107254094ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-12-3107254094ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-12-3107254094ns6:LeaseholdImprovements2021-12-3107254094ns6:FurnitureFittings2021-12-3107254094ns6:LeaseholdImprovements2022-12-3107254094ns6:FurnitureFittings2022-12-3107254094ns6:LeaseholdImprovements2021-12-3107254094ns6:FurnitureFittings2021-12-3107254094ns6:WithinOneYearns6:CurrentFinancialInstruments2022-12-3107254094ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3107254094ns6:WithinOneYear2022-12-3107254094ns6:WithinOneYear2021-12-3107254094ns6:BetweenOneFiveYears2022-12-3107254094ns6:BetweenOneFiveYears2021-12-3107254094ns6:AllPeriods2022-12-3107254094ns6:AllPeriods2021-12-31
REGISTERED NUMBER: 07254094 (England and Wales)















PHARMAPHORUM MEDIA LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022






PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PHARMAPHORUM MEDIA LIMITED

COMPANY INFORMATION
for the year ended 31 December 2022







Directors: Dr P Tunnah
Mr R Ascione
Mr F Fortini





Secretary: Mr P Bannister





Registered office: Rosemount House
Rosemount Avenue
West Byfleet
KT14 6LB





Registered number: 07254094 (England and Wales)





Auditors: Bennewith 2018 Limited
Statutory Auditors
3 Wey Court
Mary Road
Guildford
Surrey
GU1 4QU

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

BALANCE SHEET
31 December 2022

2022 2021
Notes £    £   
FIXED ASSETS
Intangible assets 4 12,938 -
Tangible assets 5 7,840 6,149
20,778 6,149

CURRENT ASSETS
Debtors 6 867,340 623,404
Cash at bank 198,253 706,889
1,065,593 1,330,293
CREDITORS
Amounts falling due within one year 7 (531,280 ) (704,754 )
NET CURRENT ASSETS 534,313 625,539
TOTAL ASSETS LESS CURRENT LIABILITIES 555,091 631,688

PROVISIONS FOR LIABILITIES (1,490 ) (1,168 )
NET ASSETS 553,601 630,520

CAPITAL AND RESERVES
Called up share capital 105 105
Retained earnings 553,496 630,415
SHAREHOLDERS' FUNDS 553,601 630,520

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 September 2023 and were signed on its behalf by:





Dr P Tunnah - Director


PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2022


1. STATUTORY INFORMATION

Pharmaphorum Media Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention unless otherwise stated below.

Turnover
Turnover represents the fair value of the consideration receivable for the sale of services in the ordinary course of the business, excluding value added tax. In the case of long term contracts, credit is taken appropriate to the stage of completion when the outcome of the contract can be assessed with reasonable certainty.

Intangible assets
Intangible fixed assets include website development costs where their future recoverability can reasonable be regarded as assured. Amortisation is provided at an annual rate of 33% on cost.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Leasehold improvements - Over the period of the lease
Office equipment - straight line over 3 years

Financial instruments
Financial assets and liabilities are recognised when the company becomes party to the contractual provisions of the instrument. All financial assets and liabilities are initially measured at transaction price. The company has no financial assets or liabilities measured at fair value through profit or loss. All subsequent remeasurement of financial assets and liabilities are recognised at amortised cost using the effective interest rate method.

Taxation
Taxation for the year comprises current and deferred tax. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2022


2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Operating leases
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred. The benefits of lease incentives are recognised in the profit and loss account over the life of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2021 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Website
development
costs
£   
Cost
At 1 January 2022 161,929
Additions 18,347
At 31 December 2022 180,276
Amortisation
At 1 January 2022 161,929
Amortisation for year 5,409
At 31 December 2022 167,338
Net book value
At 31 December 2022 12,938
At 31 December 2021 -

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2022


5. TANGIBLE FIXED ASSETS
Leasehold Office
improvements equipment Totals
£    £    £   
Cost
At 1 January 2022 33,344 32,120 65,464
Additions - 5,947 5,947
At 31 December 2022 33,344 38,067 71,411
Depreciation
At 1 January 2022 33,344 25,971 59,315
Charge for year - 4,256 4,256
At 31 December 2022 33,344 30,227 63,571
Net book value
At 31 December 2022 - 7,840 7,840
At 31 December 2021 - 6,149 6,149

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 742,206 548,128
Other debtors 125,134 75,276
867,340 623,404

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade creditors 178,963 207,283
Taxation and social security 48,417 109,947
Other creditors 303,900 387,524
531,280 704,754

PHARMAPHORUM MEDIA LIMITED (REGISTERED NUMBER: 07254094)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2022


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2022 2021
£    £   
Within one year 42,950 81,470
Between one and five years - 28,275
42,950 109,745

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

A J Bennewith FCA, FCPA, FFA, FFTA, FIPA, DChA, FRSA (Senior Statutory Auditor)
for and on behalf of Bennewith 2018 Limited

10. ULTIMATE CONTROLLING PARTY

The company is a wholly owned subsidiary of Healthware Group S.R.L., a company registered in Italy. The registered address of Healthware Group S.R.L. is Piazza Abate Conforti, Salerno (SA) 84121, Italy.

The ultimate parent company is Simon Fiduciaria S.P.A, a company also registered in Italy, by virtue of its majority ownership of Healthware Group S.R.L. The registered address of Simon Fiduciaria S.P.A. is Via Pietro Giannone 10, 10121 Torino, Italy.